LXRX
Lexicon Pharmaceuticals Inc
Price:  
1.64 
USD
Volume:  
2,839,201.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

LXRX Fair Value

-270.43 %
Upside

As of 2024-09-19, the Fair Value of Lexicon Pharmaceuticals Inc (LXRX) is -2.80 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.64 USD, the upside of Lexicon Pharmaceuticals Inc is -270.43%.

Note: valuation result may not be accurate due to the company's negative EPS.

1.64 USD
Stock Price
-2.80 USD
Fair Price
FAIR VALUE CALCULATION

LXRX Fair Value

Peter Lynch's formula is:

LXRX Fair Value
= Earnings Growth Rate x TTM EPS
LXRX Fair Value
= 5.00 x -0.56
LXRX Fair Value
= -2.80

The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings
2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31 5Y Avg
Net income 130.10 -58.60 -87.80 -101.90 -177.12 -59.06
YoY growth 207.97% -145.04% -49.83% -16.06% -73.82% -15.36%

LXRX Fair Value - Key Data

Market Cap (mil) 592.84
P/E
Forward P/E
EPS -0.56
Avg earnings growth rate -15.36%
TTM earnings -202.08